If you've been dying to get a look at a Polonator, Keith Robison has a picture of one on his blog. Robison got a look at it at the CHI Next-Gen meeting last month and he says that "the truly intriguing angle on the Polonator is that it is a completely open architecture." He adds that is "pretty enticing from a techie angle, but it's also a pretty risky business strategy." He's also thinking about what projects he could do if he were to have a Polonator.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.